ERAS (STOCKS)
Erasca, Inc. Common Stock
$11.430000
-0.520000 (-4.35%)
Prev close: $11.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jonathan E. Lim
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,580.37M
- Employees
- 129
- P/E (TTM)
- -26.51
- P/B (TTM)
- 9.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.11 | $-0.11 | -0.0046 | -4.36% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.11 | -0.0078 | -6.95% |
|
Mar 2025 (Q1)
|
$-0.11 | $-0.13 | +0.0185 | +14.40% |
|
Dec 2024 (Q4)
|
$-0.11 | $-0.13 | +0.0165 | +13.04% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.33M |
| Operating Expenses | $144.01M |
| Operating Income/Loss | -$144.01M |
| Income/Loss From Continuing Operations After Tax | -$127.69M |
| Income/Loss From Continuing Operations Before Tax | -$127.69M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$127.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$127.69M |
| Net Income/Loss Available To Common Stockholders, Basic | -$127.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 299,896,030 |
| Diluted Average Shares | 299,896,030 |
| Assets | $420.40M |
| Current Assets | $299.93M |
| Cash | $362.40M |
| Noncurrent Assets | $120.48M |
| Fixed Assets | $14.04M |
| Other Non-current Assets | $106.44M |
| Liabilities | $72.52M |
| Current Liabilities | $28.71M |
| Accounts Payable | $3.03M |
| Other Current Liabilities | $25.68M |
| Noncurrent Liabilities | $43.80M |
| Equity | $347.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $347.89M |
| Liabilities And Equity | $420.40M |
| Net Cash Flow From Operating Activities | -$98.31M |
| Net Cash Flow From Operating Activities, Continuing | -$98.31M |
| Net Cash Flow From Investing Activities | $98.33M |
| Net Cash Flow From Investing Activities, Continuing | $98.33M |
| Net Cash Flow From Financing Activities | $1.32M |
| Net Cash Flow From Financing Activities, Continuing | $1.32M |
| Net Cash Flow | $1.35M |
| Net Cash Flow, Continuing | $1.35M |
| Comprehensive Income/Loss | -$128.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$128.86M |
| Other Comprehensive Income/Loss | -$1.18M |